Navigation Links
Neural networking nanotubes

New implantable biomedical devices that can act as artificial nerve cells, control severe pain, or allow otherwise paralyzed muscles to be moved might one day be possible thanks to developments in materials science. Writing today in Advanced Materials, Nicholas Kotov of the University of Michigan, USA, and colleagues describe how they have used hollow, submicroscopic strands of carbon, carbon nanotubes, to connect an integrated circuit to nerve cells. The new technology offers the possibility of building an interface between biology and electronics.

Kotov and colleagues at Oklahoma State University and the University of Texas Medical Branch have explored the properties of single-walled nanotubes (SWNTs) with a view to developing these materials as biologically compatible components of medical devices, sensors, and prosthetics. SWNTs are formed from carbon atoms by various techniques including deposition and resemble a rolled up sheet of chicken wire, but on a tiny scale. They are usually just a few nanometers across and up to several micrometers in length.

The researchers built up layers of their SWNTs to produce a film that is electrically conducting even at a thickness of just a few nanometers. They next grew neuron precursor cells on this film. These precursor cells successfully differentiated into highly branched neurons. A voltage could then be applied, lateral to the SWNT film layer, and a so-called whole cell patch clamp used to measure any electrical effect on the nerve cells. When a lateral voltage is applied, a relatively large current is carried along the surface but only a very small current, in the region of billionths of an amp, is passed across the film to the nerve cells. The net effect is a kind of reverse amplification of the applied voltage that stimulates the nerve cells without damaging them.

Kotov and his colleagues report that such devices might find use in pain management, for instance, where nerve cells involved in the pain response might be controlled by reducing the activity of those cells. An analogous device might be used conversely to stimulate failed motor neurons, nerve cells that control muscle contraction. The researchers also suggest that stimulation could be applied to heart muscle cells to stimulate the heart.

They caution that a great deal of work is yet to be carried out before such devices become available to the medical profession.
'"/>

Source:John Wiley & Sons, Inc.


Related biology news :

1. Neural stem cell gene plays crucial role in eye development
2. Neural stem cells lend the brain a surprising capacity for self-repair
3. Neural bottleneck found that thwarts multi-tasking
4. Motorola researchers develop selective sensors based on carbon nanotubes
5. Cells selectively absorb short nanotubes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... ... Research and Markets has announced the addition of the "Global ... The report forecasts the global military biometrics market to grow at a ... has been prepared based on an in-depth market analysis with inputs from ... over the coming years. The report also includes a discussion of the ...
(Date:12/12/2016)... CLEVELAND , Dec. 12, 2016  Researchers ... commercial possibilities for graphene by combining the material ... a highly sensitive pressure detector able to sense ... of a small spider.  The ... and can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... TEL AVIV, Israel , December 7, 2016 ... year with the expansion of its patent portfolio, which grew to over ... , , ... led by its recently filed patent entitled " System, Device, ... which covers technology that enables device makers to forego costly hardware components ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... , ... January 11, 2017 , ... Back pain relief ... No Shots and No Surgery for positive back pain relief for WAR members. , ... results worldwide and could be life changing for millions suffering from chronic back pain. ...
(Date:1/11/2017)... , PITTSBURGH and BENGALURU, ... N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: ... and Drug Administration (FDA) has accepted Mylan,s biologics license ... filing through the 351(k) pathway. This product is a ... treat certain HER2-positive breast cancers. The anticipated FDA goal ...
(Date:1/11/2017)... 2017  GenVec, Inc. (NASDAQ: GNVC ... that its chief scientific officer, Douglas E. ... platform for translational development of innovative gene and ... upcoming Phacilitate Cell & Gene Therapy World 2017 ... Dr. Brough,s presentation will highlight the utility of ...
(Date:1/11/2017)... ... January 11, 2017 , ... KBioBox llc ... with Poseida Therapeutics Inc, the San Diego based specialist in gene and cell ... KBioBox in order to harness KBioBox’s powerful BioEngine Algorithms which do not compromise ...
Breaking Biology Technology: